Matti Lehtinen

23.3k total citations · 1 hit paper
289 papers, 10.2k citations indexed

About

Matti Lehtinen is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Matti Lehtinen has authored 289 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Epidemiology, 76 papers in Surgery and 58 papers in Oncology. Recurrent topics in Matti Lehtinen's work include Cervical Cancer and HPV Research (160 papers), Hepatitis B Virus Studies (74 papers) and Genital Health and Disease (50 papers). Matti Lehtinen is often cited by papers focused on Cervical Cancer and HPV Research (160 papers), Hepatitis B Virus Studies (74 papers) and Genital Health and Disease (50 papers). Matti Lehtinen collaborates with scholars based in Finland, Sweden and United States. Matti Lehtinen's co-authors include Joakim Dillner, Jorma Paavonen, Pentti Koskela, ­Eero Pukkala, Tapio Luostarinen, Egil Jellum, John T. Schiller, Heljä‐Marja Surcel, Matti Hakama and Göran Hallmans and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Matti Lehtinen

278 papers receiving 9.7k citations

Hit Papers

Human Papillomavirus Infe... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
    2001 717 citations Göran Hallmans, Egil Jellum et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Lehtinen Finland 53 5.5k 2.7k 2.0k 1.5k 1.3k 289 10.2k
David Jenkins United Kingdom 51 6.6k 1.2× 3.6k 1.3× 1.5k 0.7× 732 0.5× 1.4k 1.0× 243 11.3k
Howard D. Strickler United States 53 3.9k 0.7× 2.0k 0.7× 2.7k 1.4× 702 0.5× 602 0.5× 227 8.6k
Alex Ferenczy Canada 56 6.8k 1.2× 3.6k 1.3× 1.8k 0.9× 839 0.6× 1.5k 1.1× 280 12.0k
Pentti Koskela Finland 48 2.9k 0.5× 2.7k 1.0× 1.1k 0.5× 770 0.5× 855 0.7× 147 8.4k
Diane M. Harper United States 31 5.4k 1.0× 2.4k 0.9× 2.7k 1.4× 613 0.4× 1.2k 0.9× 136 8.8k
Patti E. Gravitt United States 60 10.7k 1.9× 5.1k 1.9× 2.4k 1.2× 2.3k 1.6× 1.0k 0.8× 242 13.7k
Tim Waterboer Germany 51 4.7k 0.8× 2.4k 0.9× 2.5k 1.3× 422 0.3× 1.2k 0.9× 358 9.0k
Marc Arbyn Belgium 45 9.1k 1.6× 3.0k 1.1× 3.7k 1.9× 1.4k 0.9× 474 0.4× 168 12.9k
Anna R. Giuliano United States 71 12.7k 2.3× 7.6k 2.8× 3.9k 2.0× 1.1k 0.8× 1.1k 0.8× 482 19.0k
Anna‐Barbara Moscicki United States 50 7.4k 1.3× 3.1k 1.1× 1.7k 0.8× 1.6k 1.1× 1.6k 1.2× 156 10.1k

Countries citing papers authored by Matti Lehtinen

Since Specialization
Citations

This map shows the geographic impact of Matti Lehtinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Lehtinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Lehtinen more than expected).

Fields of papers citing papers by Matti Lehtinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Lehtinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Lehtinen. The network helps show where Matti Lehtinen may publish in the future.

Co-authorship network of co-authors of Matti Lehtinen

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Lehtinen. A scholar is included among the top collaborators of Matti Lehtinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Lehtinen. Matti Lehtinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehtinen, Matti, Laia Bruni, Miriam Elfström, et al.. (2024). Scientific approaches toward improving cervical cancer elimination strategies. International Journal of Cancer. 154(9). 1537–1548. 13 indexed citations
2.
Louvanto, Karolina, Ville N. Pimenoff, Tiina Eriksson, et al.. (2024). Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions. International Journal of Cancer. 155(9). 1549–1557. 8 indexed citations
3.
Mariz, Filipe Colaço, Carina Eklund, Tiina Eriksson, et al.. (2024). Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study. npj Vaccines. 9(1). 146–146. 1 indexed citations
4.
Pimenoff, Ville N., Tiina Eriksson, Tapio Luostarinen, et al.. (2021). Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial. PLoS Medicine. 18(6). e1003588–e1003588. 12 indexed citations
5.
Lehtinen, Matti, Dan Apter, Tiina Eriksson, et al.. (2021). Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland. Cancer Medicine. 10(21). 7759–7771. 3 indexed citations
6.
Paavonen, Jorma, Renée T. Fortner, Matti Lehtinen, & Annika Idahl. (2021). Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer. The Journal of Infectious Diseases. 224(Supplement_2). S121–S127. 22 indexed citations
7.
Mariz, Filipe Colaço, Noemi Bender, Devasena Anantharaman, et al.. (2020). Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. npj Vaccines. 5(1). 14–14. 34 indexed citations
8.
Vänskä, Simopekka, Tapio Luostarinen, Iacopo Baussano, et al.. (2020). Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. The Journal of Infectious Diseases. 222(6). 948–956. 37 indexed citations
9.
Louvanto, Karolina, Tiina Eriksson, Dan Apter, et al.. (2019). Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. International Journal of Cancer. 147(2). 440–447. 8 indexed citations
10.
Palmroth, Johanna, Tapio Luostarinen, Dan Apter, et al.. (2018). Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II). International Journal of Cancer. 142(12). 2491–2500. 30 indexed citations
11.
Fortner, Renée T., Helena Schöck, Rudolf Kaaks, et al.. (2016). Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort. Cancer Research. 77(1). 134–141. 7 indexed citations
12.
Fortner, Renée T., Helena Schöck, Rudolf Kaaks, et al.. (2014). Early Pregnancy Sex Steroids and Maternal Breast Cancer: A Nested Case–Control Study. Cancer Research. 74(23). 6958–6967. 14 indexed citations
13.
Ruiz-Sternberg, Ángela María, Tiina Eriksson, Matti Lehtinen, et al.. (2012). Proximity of First Sexual Intercourse to Menarche and Risk of High-Grade Cervical Disease. The Journal of Infectious Diseases. 206(12). 1887–1896. 13 indexed citations
14.
Toriola, Adetunji T., Marja Vääräsmäki, Matti Lehtinen, et al.. (2011). Determinants of Maternal Sex Steroids During the First Half of Pregnancy. Obstetrics and Gynecology. 118(5). 1029–1036. 114 indexed citations
15.
Toriola, Adetunji T., Heljä‐Marja Surcel, Calypse Agborsangaya, et al.. (2010). Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case–control study. European Journal of Cancer. 46(15). 2799–2805. 37 indexed citations
16.
Pedersen, C, Tiina Petäjä, Gitte Strauss, et al.. (2007). Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.. Journal of Child and Adolescent Mental Health. 40. 564–571. 5 indexed citations
17.
Paavonen, Jorma, Karuna P. Karunakaran, Tarja Anttila, et al.. (2003). Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. American Journal of Obstetrics and Gynecology. 189(5). 1287–1292. 29 indexed citations
18.
Nayak, Nihar R., Ov D. Slayden, Kristof Chwalisż, Matti Lehtinen, & Robert Brenner. (2000). Antiprogestin-Releasing Intrauterine Devices: A Novel Approach to Endometrial Contraception. Fertility and Sterility. 74(3). S70–S70. 3 indexed citations
19.
Bjørge, Tone, Joakim Dillner, Tarja Anttila, et al.. (1997). Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ. 315(7109). 646–649. 58 indexed citations
20.
Lehtinen, Matti, Joakim Dillner, Paul Knekt, et al.. (1996). Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study: Table 1. BMJ. 312(7030). 537–539. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Jenkins Breakdown of academic impact, for papers by Howard D. Strickler Breakdown of academic impact, for papers by Alex Ferenczy Breakdown of academic impact, for papers by Pentti Koskela Breakdown of academic impact, for papers by Diane M. Harper Breakdown of academic impact, for papers by Patti E. Gravitt Breakdown of academic impact, for papers by Tim Waterboer Breakdown of academic impact, for papers by Marc Arbyn Breakdown of academic impact, for papers by Anna R. Giuliano Breakdown of academic impact, for papers by Anna‐Barbara Moscicki
Rankless by CCL
2026